What Makes Mesa Laboratories (MLAB) a Valuable Stock?
Diamond Hill Capital, an investment management company, released its “Small Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Mesa Laboratories Inc (MLAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 271,118 | $32,170,862 | -6% | 0.35% |
| 2. | Diamond Hill Capital Ric Dillon | 29,458 | $3,495,486 | +11% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $200.00 | 500 | Director | 500 | 2022-08-09 | Filing | |
| $0.00 | 0 | Director | 43,016 | 2019-03-31 | Filing | |
| $29.00 | 10,000 | Director, Other | 200,000 | 2011-03-03 | Filing | |
| $24.75 | 40,000 | Director, Other | 190,000 | 2010-12-21 | Filing | |
| $21.52 | 30,000 | Director, Other | 150,000 | 2010-10-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $123.91 | 21,000 | Officer | 43,337 | 2025-03-19 | Filing | |
| $111.98 | 2,551 | Officer | 43,337 | 2024-10-29 | Filing | |
| $113.62 | 2,518 | Officer | 45,888 | 2024-10-28 | Filing | |
| $125.00 | 1,499 | Officer | 0 | 2024-09-13 | Filing | |
| $112.36 | 1,500 | Officer | 558 | 2023-12-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 827,616 | $98,204,918 | 0% | |
| 2. | 571,358 | $67,797,346 | 1.02% | |
| 3. | 16,047 | $15,665,931 | 0.61% | |
| 4. | 7,982,000 | $7,800,221 | 1.14% | |
| 5. | 54,767 | $6,498,647 | 0% |
News See All
Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance
Conestoga Capital Advisors, an asset management company, released its “Micro-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Andvari Sold One of its Longest Holdings Mesa Laboratories (MLAB) in Q2
Andvari Associates, an investment management firm, released its second quarter 2024 investor letter, a copy of which can be downloaded here.
Mesa Laboratories (MLAB) Impacted by Slowdown in Pharmaceutical And Biotech Spending
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
15 Worst Performing Growth Stocks in 2023
In this piece, we will take a look at the fifteen worst performing growth stocks in 2023.
Here’s Why Mesa Laboratories (MLAB) Declined in Q2
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2023 investor letter. A copy of the same can be downloaded here.
Is Mesa Laboratories (MLAB) a Growing Stock?
Andvari Associates, an investment management company, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here.
Here's Why Mesa Laboratories (MLAB) Declined in Q3
Conestoga Capital Advisors, an asset management company, released its “Small Cap Growth Fund” third-quarter investor letter. A copy of the same can be downloaded here.
10 Best Small Cap Stocks to Buy in 2021
In this article we will take a look at the 10 best small cap stocks to buy in 2021.
Is MLAB A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Billionaire Hedge Funds
